Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.

Bauwens M, De Saint-Hubert M, Cleynhens J, Vandeputte C, Li J, Devos E.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):187-200. Epub 2013 Feb 6.

PMID:
23389693
2.

Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.

Bauwens M, De Saint-Hubert M, Devos E, Deckers N, Reutelingsperger C, Mortelmans L, Himmelreich U, Mottaghy FM, Verbruggen A.

Nucl Med Biol. 2011 Apr;38(3):381-92. doi: 10.1016/j.nucmedbio.2010.09.008. Epub 2010 Dec 3.

PMID:
21492787
3.

Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.

Cheng Q, Lu L, Grafström J, Olofsson MH, Thorell JO, Samén E, Johansson K, Ahlzén HS, Linder S, Arnér ES, Stone-Elander S.

Biochim Biophys Acta. 2013 Mar;1830(3):2562-73.

4.

18F-labelled annexin V: a PET tracer for apoptosis imaging.

Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, Tait JF, Nishimura S.

Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):469-74. Epub 2003 Dec 10.

PMID:
14666384
5.

Gallium-68-dotamaleimide-Cys2-annexin A5.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Jun 28 [updated 2011 Aug 10].

6.

Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography.

Prinsen K, Li J, Vanbilloen H, Vermaelen P, Devos E, Mortelmans L, Bormans G, Ni Y, Verbruggen A.

Bioorg Med Chem. 2010 Jul 15;18(14):5274-81. doi: 10.1016/j.bmc.2010.05.050. Epub 2010 May 24.

PMID:
20580560
7.

Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.

Mäkinen TJ, Lankinen P, Pöyhönen T, Jalava J, Aro HT, Roivainen A.

Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1259-68. Epub 2005 Jul 9.

PMID:
16007423
8.

Gallium-68-dotamaleimide-Cys165-annexin A5.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Jun 28 [updated 2011 Aug 10].

9.

PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.

Cai W, Olafsen T, Zhang X, Cao Q, Gambhir SS, Williams LE, Wu AM, Chen X.

J Nucl Med. 2007 Feb;48(2):304-10.

10.

Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET.

Reshef A, Shirvan A, Waterhouse RN, Grimberg H, Levin G, Cohen A, Ulysse LG, Friedman G, Antoni G, Ziv I.

J Nucl Med. 2008 Sep;49(9):1520-8. doi: 10.2967/jnumed.107.043919. Epub 2008 Aug 14. Erratum in: J Nucl Med. 2011 Nov;52(11):1818.

11.

Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.

Cheng Q, Lu L, Grafström J, Olofsson MH, Thorell JO, Samén E, Johansson K, Ahlzén HS, Stone-Elander S, Linder S, Arnér ES; Sel-tag Imaging Project.

PLoS One. 2012;7(8):e42151. doi: 10.1371/journal.pone.0042151. Epub 2012 Aug 1.

12.

Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone.

Ebenhan T, Honer M, Ametamey SM, Schubiger PA, Becquet M, Ferretti S, Cannet C, Rausch M, McSheehy PM.

Mol Imaging Biol. 2009 Sep-Oct;11(5):308-21. doi: 10.1007/s11307-009-0216-1. Epub 2009 May 22. Erratum in: Mol Imaging Biol. 2009 Sep-Oct;11(5):379-80.

PMID:
19462209
13.

68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.

Buchegger F, Viertl D, Baechler S, Dunet V, Kosinski M, Poitry-Yamate C, Rüegg C, Prior JO.

Nuklearmedizin. 2011;50(6):225-33. doi: 10.3413/Nukmed-0416-11-06. Epub 2011 Oct 11.

PMID:
21989840
14.

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.

Kersemans V, Cornelissen B, Kersemans K, Bauwens M, Achten E, Dierckx RA, Mertens J, Slegers G.

J Nucl Med. 2005 Mar;46(3):532-9.

15.

Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.

Zhang R, Lu W, Wen X, Huang M, Zhou M, Liang D, Li C.

J Nucl Med. 2011 Jun;52(6):958-64. doi: 10.2967/jnumed.110.083220. Epub 2011 May 13.

16.

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, Hicks RJ.

J Pharm Pharm Sci. 2007;10(2):203-11.

17.

68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG.

Dimitrakopoulou-Strauss A, Hohenberger P, Haberkorn U, Mäcke HR, Eisenhut M, Strauss LG.

J Nucl Med. 2007 Aug;48(8):1245-50. Epub 2007 Jul 13.

18.

Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Maier FC, Kneilling M, Reischl G, Cay F, Bukala D, Schmid A, Judenhofer MS, Röcken M, Machulla HJ, Pichler BJ.

Radiat Oncol. 2011 Nov 25;6:165. doi: 10.1186/1748-717X-6-165.

19.

Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.

Tarkia M, Saraste A, Saanijoki T, Oikonen V, Vähäsilta T, Strandberg M, Stark C, Tolvanen T, Teräs M, Savunen T, Green MA, Knuuti J, Roivainen A.

Nucl Med Biol. 2012 Jul;39(5):715-23. doi: 10.1016/j.nucmedbio.2011.11.007. Epub 2012 Jan 20.

PMID:
22264857
20.

Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo.

Hoffend J, Mier W, Schuhmacher J, Schmidt K, Dimitrakopoulou-Strauss A, Strauss LG, Eisenhut M, Kinscherf R, Haberkorn U.

Nucl Med Biol. 2005 Apr;32(3):287-92.

PMID:
15820764
Items per page

Supplemental Content

Write to the Help Desk